6/6/2007

Hot flashes are now seen as a stronger sign of a better prognosis for early-stage breast cancer patients on tamoxifen than age, hormone receptor status or stage of breast cancer at diagnosis. Researchers said in a study that women who experienced hot flashes were 12.9% less likely to have recurrent breast cancer.

Full Story:
Forbes

Related Summaries